SGHT Stock Analysis: Buy, Sell, or Hold?
SGHT - Sight Sciences, Inc. Common Stock
$5.20
0.30 (6.12%)
▲
5d:
-1.7%
30d:
+32.99%
90d:
-3.53%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When SGHT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SGHT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SGHT is 7.9% above its trading range ($4.82). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SGHT is 7.9% above its trading range ($4.82). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SGHT is currently trading at $5.20, which is considered extended relative to its 30-day fair value range of $3.70 to $4.82.
Technical Outlook: Technically, SGHT is in a strong downtrend. Immediate support is located at $4.09, while resistance sits at $5.66. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: SGHT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.34 (+60.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SGHT is in a strong downtrend. Immediate support is located at $4.09, while resistance sits at $5.66. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: SGHT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.34 (+60.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.70 -
$4.82
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range (+7.9% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Trading 60.3% below Wall St target ($8.34)
- CAUTION: Extended 7.9% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$3.70 -
$4.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.09
Resistance Level
$5.66
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.88
Wall Street Target
$8.34
(+60.3%)
Revenue Growth (YoY)
12.5%
Profit Margin
-46.8%
Share & Embed Analysis
Last updated: May 14, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGHT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeremy B Hayden
SELL
13761 shares
2026-04-06
James Rodberg
SELL
7231 shares
2026-04-06
David Badawi
SELL
8168 shares
2026-04-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
